Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
University of California, Davis
Hoffmann-La Roche
ViroMissile, Inc.
University of Florida
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Guerbet
Fusion Pharmaceuticals Inc.
Eli Lilly and Company
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Eli Lilly and Company
Travera Inc
Jonsson Comprehensive Cancer Center
MedSIR
University Health Network, Toronto